Fiche publication


Date publication

juin 2011

Auteurs

Membres identifiés du Cancéropôle Est :
Pr BALDAUF Jean-Jacques , Pr VELTEN Michel , Pr AKLADIOS Chérif


Tous les auteurs :
Baldauf JJ, Fender M, Akladios CY, Velten M

Résumé

Pap smear screening of women under 25 years old remains controversial. No randomized study exists on this topic. The perception of individual benefit often prevails, although there is no proof of effectiveness and no demonstrated risk-benefit ratio. A review of published studies - taking into account epidemiological data, effectiveness of screening of young women, adverse medical outcomes and costs - suggests that there are more arguments against screening before 25 than in favour of it.

Référence

Gynecol Obstet Fertil. 2011 Jun;39(6):358-63